Medgenics Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Medgenics (MDGN) Misses Q2 EPS by 32c
August 10, 2015 8:14 AM EDTMedgenics (NYSE: MDGN) reported Q2 EPS of ($0.63), $0.32 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Medgenics (MDGN) click here.
... More